IMC-G107C

N/A

Report date: 2026/03/19 17:03:30

Base Information

Drug NameIMC-G107C

Drug Alias NameIMC-G107C

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionImmunomodulatorsT cell surface glycoprotein CD3 inhibitorsT-cell receptor modulators

TargetsT cell surface glycoprotein CD3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunocore Ltd

China Registration ClassN/A

Develop Information

Active CompaniesImmunocore Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A